Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer
Jenna H. Newman, David J. Augeri, Rachel Nemoyer, Jyoti Malhotra, Elaine Langenfeld, Charles B. Chesson, Natalie S. Dobias, Michael J. Lee, Saeed Tarabichi, Sachin R. Jhawar, Praveen K. Bommareddy, Sh'Rae Marshall, Evita T. Sadimin, John E. Kerrigan, Michael Goedken, Christine Minerowicz, Salma K. Jabbour, Shengguo Li, Mary O. Carayannopolous, Andrew ZlozaJohn Langenfeld
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer'. Together they form a unique fingerprint.